Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis - PubMed (original) (raw)
. 2009 Feb 27;323(5918):1205-8.
doi: 10.1126/science.1166066.
D A Bosco, A L Leclerc, E Tamrazian, C R Vanderburg, C Russ, A Davis, J Gilchrist, E J Kasarskis, T Munsat, P Valdmanis, G A Rouleau, B A Hosler, P Cortelli, P J de Jong, Y Yoshinaga, J L Haines, M A Pericak-Vance, J Yan, N Ticozzi, T Siddique, D McKenna-Yasek, P C Sapp, H R Horvitz, J E Landers, R H Brown Jr
Affiliations
- PMID: 19251627
- DOI: 10.1126/science.1166066
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis
T J Kwiatkowski Jr et al. Science. 2009.
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal degenerative motor neuron disorder. Ten percent of cases are inherited; most involve unidentified genes. We report here 13 mutations in the fused in sarcoma/translated in liposarcoma (FUS/TLS) gene on chromosome 16 that were specific for familial ALS. The FUS/TLS protein binds to RNA, functions in diverse processes, and is normally located predominantly in the nucleus. In contrast, the mutant forms of FUS/TLS accumulated in the cytoplasm of neurons, a pathology that is similar to that of the gene TAR DNA-binding protein 43 (TDP43), whose mutations also cause ALS. Neuronal cytoplasmic protein aggregation and defective RNA metabolism thus appear to be common pathogenic mechanisms involved in ALS and possibly in other neurodegenerative disorders.
Similar articles
- Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, Tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE. Vance C, et al. Science. 2009 Feb 27;323(5918):1208-1211. doi: 10.1126/science.1165942. Science. 2009. PMID: 19251628 Free PMC article. - Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
Tradewell ML, Yu Z, Tibshirani M, Boulanger MC, Durham HD, Richard S. Tradewell ML, et al. Hum Mol Genet. 2012 Jan 1;21(1):136-49. doi: 10.1093/hmg/ddr448. Epub 2011 Sep 28. Hum Mol Genet. 2012. PMID: 21965298 - FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
Suzuki N, Kato S, Kato M, Warita H, Mizuno H, Kato M, Shimakura N, Akiyama H, Kobayashi Z, Konno H, Aoki M. Suzuki N, et al. J Neuropathol Exp Neurol. 2012 Sep;71(9):779-88. doi: 10.1097/NEN.0b013e318264f164. J Neuropathol Exp Neurol. 2012. PMID: 22878663 - TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
Strong MJ, Volkening K. Strong MJ, et al. FEBS J. 2011 Oct;278(19):3569-77. doi: 10.1111/j.1742-4658.2011.08277.x. Epub 2011 Sep 6. FEBS J. 2011. PMID: 21810174 Review. - Molecular basis of amyotrophic lateral sclerosis.
Liscic RM, Breljak D. Liscic RM, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):370-2. doi: 10.1016/j.pnpbp.2010.07.017. Epub 2010 Jul 23. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 20655970 Review.
Cited by
- Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities.
Samuel Olajide T, Oyerinde TO, Omotosho OI, Okeowo OM, Olajide OJ, Ijomone OM. Samuel Olajide T, et al. Neuroprotection. 2024 Sep;2(3):182-195. doi: 10.1002/nep3.56. Epub 2024 Sep 15. Neuroprotection. 2024. PMID: 39364217 Free PMC article. - The roles of TAF1 in neuroscience and beyond.
Crombie EM, Cleverley K, Timmers HTM, Fisher EMC. Crombie EM, et al. R Soc Open Sci. 2024 Sep 25;11(9):240790. doi: 10.1098/rsos.240790. eCollection 2024 Sep. R Soc Open Sci. 2024. PMID: 39323550 Free PMC article. Review. - ALS-associated C21ORF2 variant disrupts DNA damage repair, mitochondrial metabolism, neuronal excitability and NEK1 levels in human motor neurons.
Zelina P, de Ruiter AA, Kolsteeg C, van Ginneken I, Vos HR, Supiot LF, Burgering BMT, Meye FJ, Veldink JH, van den Berg LH, Pasterkamp RJ. Zelina P, et al. Acta Neuropathol Commun. 2024 Sep 4;12(1):144. doi: 10.1186/s40478-024-01852-6. Acta Neuropathol Commun. 2024. PMID: 39227882 Free PMC article. - Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types.
Holtman IR, Glass CK, Nott A. Holtman IR, et al. Adv Neurobiol. 2024;37:531-544. doi: 10.1007/978-3-031-55529-9_29. Adv Neurobiol. 2024. PMID: 39207711 Review. - Post-Translational Variants of Major Proteins in Amyotrophic Lateral Sclerosis Provide New Insights into the Pathophysiology of the Disease.
Bedja-Iacona L, Richard E, Marouillat S, Brulard C, Alouane T, Beltran S, Andres CR, Blasco H, Corcia P, Veyrat-Durebex C, Vourc'h P. Bedja-Iacona L, et al. Int J Mol Sci. 2024 Aug 8;25(16):8664. doi: 10.3390/ijms25168664. Int J Mol Sci. 2024. PMID: 39201350 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous